Most sold healthcare stocks in Q2 2011
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2011, measured as net reductions in reported share positions from Q1 2011 into Q2 2011. Notable reductions at the top of this list include JOHNSON & JOHNSON (JNJ), MERCK & CO. INC. (MRK), PFIZER INC (PFE). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | -936,648 | -$45.19M | 0 | 0 | 1 | 0 | 1 |
| MRK | MERCK & CO. INC. | -200,000 | -$3.34M | 0 | 0 | 1 | 0 | 1 |
| PFE | PFIZER INC | -100,200 | -$1.44M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q2 2011
What are the most sold Healthcare stocks in Q2 2011?
The most sold healthcare stocks in Q2 2011 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2011, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2011?
Among filers in this sector, net reductions were largest in companies such as JOHNSON & JOHNSON (JNJ), MERCK & CO. INC. (MRK), PFIZER INC (PFE), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2011).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.